Harvard Holds Firm on Bitcoin ETF Shares as AlphaPepe Offers Earlier-Stage Upside

Harvard University's endowment has reportedly stopped selling its Bitcoin ETF shares, which is seen as a positive sign for the market. According to recent filings, Harvard held around 3 million shares of BlackRock's IBIT Bitcoin ETF, worth about $101 million, unchanged in the second quarter after cutting the position two quarters in a row.

This move is significant because it suggests that even prestigious institutions like Harvard are treating Bitcoin as a durable allocation rather than a passing trade. This is also reflected in other large players holding or adding their Bitcoin ETF exposure last quarter while only a few trimmed, indicating a market consolidating rather than fleeing.

However, the article also highlights AlphaPepe, an earlier-stage investment opportunity that offers a potentially bigger upside compared to buying Bitcoin directly. With its Stage 20 presale price at $0.02654 and a target of $1 (38x) on a fixed one-billion supply, AlphaPepe provides an asymmetrical shot for early investors.

The article notes that the entry math is why buyers are moving now, with the bonus attached to the Stage 20 price set to rise as the stage steps up. This means that waiting may result in facing both a higher stage price and a potentially lost bonus, while moving now locks in the low entry and extra tokens together.

In summary, Harvard's decision to hold its Bitcoin ETF shares steady is a positive sign for the market, but AlphaPepe offers an earlier-stage investment opportunity with potentially bigger upside for early investors.